CN103768499A

CN103768499A - Medicine for treating hyperplasia of mammary glands

Info

Publication number: CN103768499A
Application number: CN201210409100.0A
Authority: CN
Inventors: 冷春华
Original assignee: Individual
Current assignee: Individual
Priority date: 2012-10-24
Filing date: 2012-10-24
Publication date: 2014-05-07

Abstract

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a medicine for treating hyperplasia of mammary glands. The hyperplasia of mammary glands is a most common female breast disease, and the incidence rate thereof accounts for the first place of breast diseases The hyperplasia of mammary glands refers to the hyperplasia of mammary epithelium and fibrous tissue, structural degenerative lesions of mammary tissue ducts and mammary lobular and progressive connective tissue growth, the pathogenesis of the hyperplasia of mammary glands is mainly due to endocrine hormone disorders. The invention provides the medicine for treating the hyperplasia of mammary glands, the medicine can promote qi and blood, homogenize ren and he and smoothen the mammary veins to achieve the treatment purpose of dissipation of mammary nodules, and the medicine comprises the following components by weight: 20-40 parts of prunella vulgaris, 10-20 parts of spreading hedyotis herb, 20-40 parts of radix scrophulariae, 20-40 parts of raw oysters, 8-12 parts of salvia miltiorrhiza, parts of laminaria japonica, 0-15 parts of ginger processed pinellia, 8-12 parts of rhizoma sparganii, 10-15 parts of seaweed, 5-15 parts of pericarpium citri reticulatae viride, 7-13 parts of dried orange peel, 5-10 parts of curcuma rhizome, 10-15 parts of radix bupleuri, 10-15parts of white peony root, 10-15 parts of cyperus rotundus, 10-15 parts of curcuma tuber and 10-20 parts of astragalus membranaceus.

Description

A kind of medicine for the treatment of cyclomastopathy

Technical field

The invention belongs to technical field of Chinese medicines, is a kind of medicine for the treatment of cyclomastopathy specifically.

Background technology

Cyclomastopathy is the modal cystic hyperplasia of breast of women, and its sickness rate accounts for the first place of mastopathy.This disease sickness rate was the trend rising year by year in the last few years, and the age also more and more becomes younger.Many women have cyclomastopathy in various degree, are more common in the women of 25～45 years old.

Cyclomastopathy refers to breast epithelium and proliferation of fibrous tissue, mammary gland tissue conduit and newborn lobule degeneration structurally and the growth of carrying out property connective tissue, and its pathogenic factor is mainly due to endocrine hormone imbalance.That which reason causes endocrine hormone disorder? the traditional Chinese medical science is thought: feelings are not smooth, and irritability must not normally be dredged and be rushed down and qi stagnation blood stasis disease is solidifying, and disharmony of Chong and Conception Channels person, often has menoxenia, facial colour spot.

Summary of the invention

The invention provides a kind of medicine for the treatment of cyclomastopathy, make QI and blood logical, punching appoint and, newborn network is smooth, thereby reaches the therapeutic purposes that nodule in the breast dissipates.

The present invention is achieved through the following technical solutions: a kind of medicine for the treatment of cyclomastopathy, is characterized in that: become to be grouped into by following weight portion: Spica Prunellae 20-40 part, Herba Hedyotidis Diffusae 10-20 part, Radix Scrophulariae 20-40 part, Concha Ostreae 20-40 part, Radix Salviae Miltiorrhizae 8-12 part, Thallus Laminariae (Thallus Eckloniae) 10-20 part, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 10-15 part, Rhizoma Sparganii 8-12 part, Sargassum 10-15 part, Pericarpium Citri Reticulatae Viride 5-15 part, Pericarpium Citri Reticulatae 7-13 part, Rhizoma Curcumae 5-10 part, Radix Bupleuri 10-15 part, Radix Paeoniae Alba 10-15 part, Rhizoma Cyperi 10-15 part, Radix Curcumae 10-15 part, Radix Astragali 10-20 part.

Take each herbal medicine by formula proportion and be ground into respectively fine powder, be processed into said tablet, powder, pill, granule or capsule in pharmaceutics by traditional pharmaceutical technology.

The generation of cyclomastopathy and endocrine regulation, lutein secretion reduces, and estrogen secretion increases relevant relatively.The traditional Chinese medical science is thought, though primary disease is sick at breast, and pathogenesis complexity.Liver controlling conveyance and dispersion, breast breast is led by liver, and nipple is Liver Channel institute mistake, and breast should lead to and should not close.If stagnation of liver-QI is suffered from a deficiency of the kidney, punching is thousand obstructed, functional activity of QI being not smooth, and the newborn network stasis of blood is stagnant, the disease that cause that the stagnation of QI, expectorant are solidifying, the stasis of blood accumulates in breast and become addiction.Treatment adopts dispersing liver and promoting blood circulation, dissipating phlegm and resolving masses, the method for tonifying Chong and Ren channels.

The present invention is pure Chinese medicinal preparation, can promoting blood circulation, dredging meridian and relieving pain, and dissipating phlegm and resolving masses, Chong and Ren Meridians regulating, cure rate is high, can not have side effects.

The specific embodiment

A medicine for the treatment of cyclomastopathy, is characterized in that: become to be grouped into by following weight portion: 30 parts of Spica Prunellaes, 15 parts of Herba Hedyotidis Diffusaes, 30 parts of Radix Scrophulariaes, 30 parts of Concha Ostreae, 9 parts of Radix Salviae Miltiorrhizaes, 15 parts of Thallus Laminariae (Thallus Eckloniae)s, 12 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 9 parts of Rhizoma Sparganii, 12 parts of Sargassums, 9 parts, Pericarpium Citri Reticulatae Viride, 9 parts of Pericarpium Citri Reticulataes, 6 parts of Rhizoma Curcumae, 12 parts of Radix Bupleuri, 12 parts of the Radix Paeoniae Albas, 12 parts of Rhizoma Cyperis, 12 parts of Radix Curcumaes, 15 parts of the Radixs Astragali.

Claims

1. a medicine for the treatment of cyclomastopathy, is characterized in that: become to be grouped into by following weight portion: Spica Prunellae 20-40 part, Herba Hedyotidis Diffusae 10-20 part, Radix Scrophulariae 20-40 part, Concha Ostreae 20-40 part, Radix Salviae Miltiorrhizae 8-12 part, Thallus Laminariae (Thallus Eckloniae) 10-20 part, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 10-15 part, Rhizoma Sparganii 8-12 part, Sargassum 10-15 part, Pericarpium Citri Reticulatae Viride 5-15 part, Pericarpium Citri Reticulatae 7-13 part, Rhizoma Curcumae 5-10 part, Radix Bupleuri 10-15 part, Radix Paeoniae Alba 10-15 part, Rhizoma Cyperi 10-15 part, Radix Curcumae 10-15 part, Radix Astragali 10-20 part.